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Abstracts / Osteoarthritis and Cartilage 22 (2014) S1–S6S4Physical activity is a more recent addition to non-pharmaceutical
interventions. In 2008, the US published federal guidelines recom-
mending adults with arthritis participate in 150 minutes of moderate
activity each week accumulated in sessions lasting at least 10 minutes.
Physical activity beneﬁts are supported by dose-response relationships
with better physical function based on longitudinal cohort studies. RCTs
demonstrate the effectiveness of both exercise interventions and
resistance training to improve function and reduce disability in adults
with knee OA. Recent RCTs provide insight into the synergy between
weight loss and physical activity in knee OA. Exercise alone and weight
loss alonewere each effective to improve function; however weight loss
plus exercise had the greatest effect.
These studies support interventions which increase moderate intensity
activity. However, many adults are not candidates to engage in mod-
erate intensity activities due to health limitations. What strategies are
available to these adults? Recent work demonstrated sedentary
behavior is a signiﬁcant risk factor for functional loss in adults including
those with knee OA. Importantly, this relationship is independent of
obesity status and of time spent in moderate intensity activities. These
ﬁndings support replacing sedentary timewith light activity to improve
health outcomes in adults with knee OA who cannot perform/increase
moderate intensity activities.
Taken as a whole, life style interventions provide important strategies
to prevent knee OA and mitigate its consequences. Weight control can
reduce the risk of developing knee OA. For overweight adults with
knee OA, weight loss can effectively improve function. Engaging in
physical activity of moderate intensity can improve function and
reduce disability. Weight loss combined with increased activity pro-
vides added beneﬁts for overweight adults. While the beneﬁts of
physical activity are substantial, not all older adults are candidates to
engage in moderate intensity activities. An alternative strategy is to
replace time spent in sedentary behavior with light intensity activities
to improve function.
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BE IT RESOLVED: PLAIN RADIOGRAPHY OR MRI – WHICH IS BETTER
IN ASSESSING OUTCOME IN CLINICAL TRIALS?
F. Eckstein y, M.-P. Hellio Le Graverand z. y Paracelsus Med. Univ.,
Salzburg, Austria; z Pﬁzer Dev. Japan, Tokyo, Japan
Purpose: Imaging in clinical trials is commonly used to evaluate the
efﬁcacy of a therapeutic intervention, but also for subject eligibility and
safety. The results of clinical trials can support decision making in
DMOAD development, by ascertaining treatment effects on joint
structure, potentially before these translate to clinical beneﬁts. This
debate will focus on the use of radiography and magnetic resonance
imaging (MRI) in research trials and in clinical trials of knee osteo-
arthritis. Depending on the context, the strength and weaknesses of
each imaging technique will be highlighted and performance will be
compared.
Methods: The authors have performed a full-text literature on imaging
of the knee, with a focus on bone and cartilage, adding primary expe-
rience in the implementation of imaging methods in clinical trials, and
results presented at recent conferences.
Results: The authors will present summary data on the reliability
(consistency, test-retest precision) of radiographic measurement of
joint space width (JSW) and cartilage thickness with MRI. They will
address the construct, concurrent and predictive validity of both
methods, compare their sensitivity to change in knee OA in studies that
examined JSW and cartilage thickness change in the same subjects, and
highlight the speciﬁc potential and the limitations of each imaging
technique. Finally, the correlation with clinical outcomes and the
response to treatment will be addressed.
Conclusion: Current imaging methodologies provide powerful tools for
evaluating morphological and compositional aspects of most articular
tissues, capturing longitudinal change with reasonable to excellent
sensitivity. Radiography and MRI are complementary imaging techni-
ques; each has speciﬁc strengths and weaknesses that depend on the
speciﬁc context of the questions asked. When employed properly, each
of them involves potential for ascertaining treatment effects on joint
structure, potentially over shorter time scales than required for dem-
onstrating effects on clinical outcomes.I-11
NON-CARTILAGE CHANGES VISUALIZED BY MRI AND RISK FOR OA
DEVELOPMENT/PROGRESSION
M.D. Crema. Boston Univ., Boston, MA, United States
Non-cartilaginous tissues that may be affected in osteoarthritis (OA)
include the subchondral bone, synovium, ﬁbrocartilage, ligaments and
muscles. Due to its capability to visualize pathology in different tissues
with excellent contrast, magnetic resonance imaging (MRI) provides
high-resolution andmultiplanar assessment of the bone and soft tissues
mentioned above. The use of semiquantitative and quantitative MRI
biomarkers of non-cartilaginous tissues in clinical and epidemiological
OA studies is reviewed. Bone marrow lesions (BMLs) are deﬁned onMRI
as non-cystic subchondral areas of ill-deﬁned hyperintensity on ﬂuid-
sensitive spin-echo sequences, and were shown to be associated with
incidence and progression of knee OA, including progression of MRI-
detected cartilage loss and radiographically detected joint space nar-
rowing (JSN). MRI is the best imaging method for the detection and
grading of BMLs. The close relationship between BMLs and cartilage
damage in the same region of the joint was extensively demonstrated in
previous studies. BMLs represent a highly variable feature in patients
with or at risk for development of knee OA, as their size may increase or
decrease over time. This is of relevance since it was demonstrated that
the ﬂuctuation of BML size over time seems to have a direct effect on
progression of disease assessed on a subregional basis. MRI is also
capable to accurately assess the morphology of the subchondral bone,
especially in the detection of any degree of subchondral ﬂattening or
depression, also known as subchondral bone attrition. A strong asso-
ciation exists between subchondral bone attrition and subchondral
BMLs in the same region of the knee, and the association increases with
BML size. Further, it was demonstrated that attrition represents a risk
factor for progression of cartilage loss in the same compartment of the
knee. Meniscal damage including tears and maceration, as well as
meniscal extrusion, were shown to be independently associated with
incidence and progression of OA, including progression of radio-
graphically-detected JSN and MRI-detected cartilage loss. MRI is the
method of choice in the assessment of meniscal damage and meniscal
extrusion, with multiplanar spin-echo techniques being the most
appropriate for their detection and grading. Although synovitis in OA is
thought to be a secondary phenomenon related to cartilage deterio-
ration, its importance in the OA process is well recognized. Several
methods for detecting and quantifying synovitis with non-enhanced
and contrast-enhanced MRI are available. Synovitis should be ideally
assessed and quantiﬁed using gadolinium-enhanced MRI, although
surrogate markers for synovitis on non-enhanced MRI are available and
are widely utilized in published studies. There is little evidence that
synovitis is not only a secondary phenomenon in patients with knee OA
but may also play a role in progression of disease. This relationship
remains to be demonstrated in large longitudinal studies. Alternatively,
synovitis can be evaluated in combination with effusion on ﬂuid-sen-
sitive sequences but differentiation between inﬂamed synovium and
joint ﬂuid ﬁlling the joint cavity surrounded by synovium may be dif-
ﬁcult. Ligament injury can be accurately depicted by multiplanar MRI
assessment of joints. In the knee, it was demonstrated that cruciate
ligament deﬁciency secondary to tears increase the risk for incidence or
progression of OA. Further, it was shown that collateral ligaments at
both distal and proximal interphalangeal joints may play a role in early
stages of OA. The role of other non-cartilaginous tissues accurately
assessed by MRI, such as the acetabular labrum (hip) and quadriceps
muscle (knee), and their relationship with structural deterioration in
these joints was also demonstrated in a few studies. This presentation
reviews the role of non-cartilage structures, as well as pathology in
these structures, in the development and/or progression of OA, focusing
in the knee joint, based on the evidence in the literature.
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GENETICS/GENOMICS IN OSTEOARTHRITIS
A. Tsezou. Univ. of Thessaly, Faculty of Med., Larissa, Greece
In this year review recent developments in genetics/genomics of
osteoarthritis (OA) are discussed to improve our understanding of OA
pathophysiology. In OA genetics, a meta-analysis of genome wide
association studies (GWAS) revealed novel loci for hip OA, among which
